Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tu, Jian Fei ^a   Ding, Ya Hui ^b   Ying, Xi Hui ^a   Wu, Fa Zong ^a   Zhou, Xin Mu ^a   Zhang, Deng Ke ^a   Zou, Hai ^b   Ji, Jian Song ^a  

^a LISHUI CENTRAL HOSPITAL   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; ICOS PROTEIN, HUMAN; INDUCIBLE T CELL COSTIMULATOR;

ADULT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RANDOMIZATION; REGULATORY T LYMPHOCYTE; SURVIVAL ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ADULT; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; RANDOM ALLOCATION; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY; TUMOR MICROENVIRONMENT;

EID: 84991501368     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35056     Document Type: Article

References (32)

1. Forner, A., Llovet, J. M., & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012
2. Hao, X. S., et al. Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population. Eur J Cancer Prev 12, 273-279 (2003
3. Budhu, A., et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10, 99-111 (2006
4. Grivennikov, S. I., Greten, F. R., & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010
5. Galon, J., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964 (2006
6. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. Pillars article: immunologic self-Tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-Tolerance causes various autoimmune diseases. J. Immunol. 1995. J Immunol 186, 3808-3821 (2011
7. Beyer, M., & Schultze, J. L. Regulatory T cells in cancer. Blood 108, 804-811 (2006
8. Hori, S., & Sakaguchi, S. Foxp3: a critical regulator of the development, and function of regulatory T cells. Microbes Infect 6, 745-751 (2004
9. Dieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., & Schuler, G. Human CD4(+ )CD25(+ ) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 196, 247-253 (2002
10. Longhi, M. S., et al. Functional study of CD4+ CD25+ regulatory T cells in health, and autoimmune hepatitis. J Immunol 176, 4484-4491 (2006
11. Wolf, D., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11, 8326-8331 (2005
12. Curiel, T. J., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege, and predicts reduced survival. Nat Med 10, 942-949 (2004
13. Liyanage, U. K., et al. Prevalence of regulatory T cells is increased in peripheral blood, and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169, 2756-2761 (2002
14. Miller, A. M., et al. CD4+ CD25high T cells are enriched in the tumor, and peripheral blood of prostate cancer patients. J Immunol 177, 7398-7405 (2006
15. Woo, E. Y., et al. Regulatory CD4(+ )CD25(+ ) T cells in tumors from patients with early-stage non-small cell lung cancer, and latestage ovarian cancer. Cancer Res 61, 4766-4772 (2001
16. Sasada, T., Kimura, M., Yoshida, Y., Kanai, M., & Takabayashi, A. CD4+ CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98, 1089-1099 (2003
17. Kono, K., et al. CD4(+ )CD25high regulatory T cells increase with tumor stage in patients with gastric, and esophageal cancers. Cancer Immunol Immunother 55, 1064-1071 (2006
18. Gogali, F., et al. Phenotypical analysis of lymphocytes with suppressive, and regulatory properties (Tregs), and NK cells in the papillary carcinoma of thyroid. J Clin Endocrinol Metab 97, 1474-1482 (2012
19. Kornete, M., Sgouroudis, E., & Piccirillo, C. A. ICOS-dependent homeostasis, and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188, 1064-1074 (2012
20. Strauss, L., et al. Expression of ICOS on human melanoma-infiltrating CD4+ CD25highFoxp3+ T regulatory cells: implications, and impact on tumor-mediated immune suppression. J Immunol 180, 2967-2980 (2008
21. Huang, X. M., et al. Role of plasmacytoid dendritic cells, and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer. Cancer Sci 105, 150-158 (2014
22. Yu, H., et al. Regulatory T cells, and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-Toxic goiter. Endocrine 44, 172-181 (2013
23. Chen, K. J., et al. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med Oncol 29, 1817-1826 (2012
24. Wada, Y., Nakashima, O., Kutami, R., Yamamoto, O., & Kojiro, M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27, 407-414 (1998
25. Gao, Q., et al. Intratumoral balance of regulatory, and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25, 2586-2593 (2007
26. Kobayashi, N., et al. FOXP3+ regulatory T cells affect the development, and progression of hepatocarcinogenesis. Clin Cancer Res 13, 902-911 (2007
27. Lin, S. Z., et al. Prediction of recurrence, and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila) 6, 594-602 (2013
28. Jochems, C., & Schlom, J. Tumor-infiltrating immune cells, and prognosis: the potential link between conventional cancer therapy, and immunity. Exp Biol Med (Maywood) 236, 567-579 (2011
29. Huang, Y., et al. Tumor-infiltrating FoxP3+ Tregs, and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Digestion 86, 329-337 (2012
30. de Rezende, L. C., Silva, I. V., Rangel, L. B., & Guimaraes, M. C. Regulatory T cell as a target for cancer therapy. Arch Immunol Ther Exp (Warsz) 58, 179-190 (2010
31. Reboldi, A., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10, 514-523 (2009
32. Sallusto, F., & Baggiolini, M. Chemokines, and leukocyte traffic. Nat Immunol 9, 949-952 (2008